Does science save lives during this pandemic?

 

- Did science save lives during this pandemic that we are still in?

- Are Biomedical and Bioengineering Sciences interesting and important subjects?

 

 “Yes!” many of today’s high school students will say that without hesitation.  But is science research a field where you want to build a career? Many students may still want to say “Yes…” but maybe blindly.

 

Scintillon Institute, a premium San Diego research institution for nonprofit purposes, has built its now famous Scintillon “SURE” (SUmmer REsearch) program to help top-performing high school students to find out for themselves whether conducting scientific research and becoming a career scientist is for them. 

Read more
1 reaction Share

Does science save lives?

- Did science save lives during this pandemic that we are still in?

- Are Biomedical and Bioengineering Sciences interesting and important subjects?

 

 “Yes!” many of today’s high school students will say that without hesitation.  But is science research a field where you want to build a career? Many students may still want to say “Yes…” but maybe blindly.

 

Scintillon Institute, a premium San Diego research institution for nonprofit purposes, has built its now famous Scintillon “SURE” (SUmmer REsearch) program to help top-performing high school students to find out for themselves whether conducting scientific research and becoming a career scientist is for them. 

Read more
1 reaction Share

A New Twist in the Tale of Experimental Immunotherapies for Parkinson’s Disease

A New Twist in the Tale of Experimental Immunotherapies for Parkinson’s Disease

A new study co-led by Scintillon Institute’s Associate Professor, Dr. Rajesh Ambasudhan, and Adjunct Professor Dr. Stuart Lipton (also a practicing Neurologist at UC San Diego) shows that certain immunotherapy approaches for Parkinson’s disease (PD) may cause harmful neuroinflammation by activating microglia (brain’s immune cells) and that this adverse effect could offset therapeutic benefits elicited by the antibody treatment. The study appeared in the April 13, 2021 issue of the Proceedings of the National Academy of Science of the United States of America.

Read more
1 reaction Share

A New Twist in the Tale of Experimental Immunotherapies

A New Twist in the Tale of Experimental Immunotherapies for Parkinson’s Disease


A new study co-led by Scintillon Institute’s Associate Professor, Dr. Rajesh Ambasudhan, and Adjunct Professor Dr. Stuart Lipton (also a practicing Neurologist at UC San Diego) shows that certain immunotherapy approaches for Parkinson’s disease (PD) may cause harmful neuroinflammation by activating microglia (brain’s immune cells) and that this adverse effect could offset therapeutic benefits elicited by the antibody treatment. The study appeared in the April 13, 2021 issue of the Proceedings of the National Academy of Science of the United States of America.

Read more
1 reaction Share

Celebrating Scintillon wins in early 2021

The Scintillon Institute is proud to announce the recent addition to its faculty, Dr. Albert Chen, who is a neurobiologist and a leading expert who specializes in examining the link between neural circuits and behavior in health and disease. 

Albert Chen joins Scintillon Institute as an Associate Professor of Neuroscience after spending eight years at the Nanyang Technological University in Singapore. Research in his lab employs a multidisciplinary approach to define the molecular, anatomical, and functional distinctions of brain centers important for coordination and refinement of movement, motor learning, and complex motivated behaviors using genetic and viral circuit tracing, neural manipulations, deep brain imaging and quantitative behavioral approaches in mice.

 

Albert_Chen.jpg

Read more
1 reaction Share